10.01.2015 Views

Download full PDF - UBC Medical Journal

Download full PDF - UBC Medical Journal

Download full PDF - UBC Medical Journal

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

YEAR 2<br />

vascular hypertrophy were significantly decreased in the VEGFtreated<br />

animals. Four weeks after gene transfer, the plasmid<br />

VEGF transcript was still detectable in the pulmonary tissue of<br />

animals injected with VEGF-transfected cells, demonstrating<br />

survival of the transfected cells and persistent transgene<br />

expression. In addition, delay of cell-based gene transfer until<br />

after the development of pulmonary hypertension also resulted in<br />

a significant decrease in the progression of RV hypertension and<br />

hypertrophy.<br />

These results indicate that cell-based VEGF gene transfer is an<br />

effective method of preventing the development and progression<br />

of pulmonary hypertension in the monocrotaline model and<br />

suggest a potential therapeutic role for angiogenic factors in the<br />

therapy of this devastating disease.<br />

P16INK4A Immunoexpression – A<br />

Negative Predictive Marker for High-<br />

Risk HPV in Oral Precancers<br />

Alexander Suen 1 , Esther Chen 2 , Tarinee Lubpairee 3 ,<br />

Yuqi Zhu 3 , Catherine F. Poh 3<br />

1<br />

Faculty of Medicine, The University of British Columbia<br />

2<br />

Department of Biomedical Physiology and Kinesiology, Simon<br />

Fraser University<br />

3<br />

Faculty of Dentistry, The University of British Columbia<br />

Studies have shown a strong correlation between high-risk HPVs<br />

(HPV-HR) and a subset of head and neck cancer with a better<br />

survival outcome. Currently there is no gold standard or “lab<br />

friendly” markers for HPV detection in head and neck cancers.<br />

Due to the availability and readiness, immunohistochemical<br />

detection of p16 has been used widely in pathology laboratories as<br />

a surrogate marker for the presence of HPV-HR in cervical cancer<br />

and precancers, but not for those at oral and oro-pharyngeal sites.<br />

Objectives: 1) To explore the presence of HPV-HR in precancers<br />

of oral and oro-pharyngeal site using chromogenic in-situ<br />

hybridization (CISH) and 2) To correlate the presence of p16 and<br />

HPV-HR.<br />

Methodology: A total of 205 oral mucosal lesions diagnosed as<br />

cancer, precancer, and normal (N=24) were analyzed for HPV-<br />

HR (Cocktail for types 16/18/31/33/35/39/45/51/52/56/58/59/68<br />

and HPV16/18) using CISH and p16 using immunohistochemisty<br />

(IHC).<br />

Results: Fourteen percent of cases showed the presence of<br />

HPV-HR with site predilection (28% soft palate complex vs.<br />

13% anterior mouth, P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!